Coloplast A/S
F:CBHD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coloplast A/S
F:CBHD
|
DK |
|
A
|
Advantest Corp
XMUN:VAN
|
JP |
Intrinsic Value
The intrinsic value of 
Coloplast A/S (CBHD) under the Base Case is 80.43 EUR per share.
Compared with the current market price of 64.42 EUR, the stock appears
Undervalued by 20% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Coloplast A/S Does
Coloplast A/S makes medical devices for people with intimate and chronic care needs. Its main products help with ostomy care, continence care, wound and skin care, and urology. These are usually disposable products such as bags, catheters, and dressings that patients use every day or healthcare professionals use in treatment.
- Headquarters
- Denmark DK
- Employees
- 12 500
- IPO date
- Jan 1, 1983
Coloplast A/S has no economic moat
Customers can choose among rival ostomy and continence products based on fit, and using Coloplast products does not make them more valuable to other users. Its name and range have not been shown to let it charge more for comparable products or keep rivals from competing for the same customers.
Read the full moat analysis
Earnings Waterfall
Coloplast A/S
The intrinsic value for Coloplast A/S (CBHD) under the Base Case is 80.43 EUR.
Compared with the current market price of 64.42 EUR, the stock appears Undervalued by 20% .